The effectiveness of this S-3 shelf, combined with the prior S-1 effectiveness, signals that CytoDyn is actively positioning for capital raises. Monitor for any takedown announcements or prospectus supplements that would indicate actual share sales, which could pressure the stock price further. The large warrant component (384,925,833 shares) also creates additional overhang if those warrants are exercised.
Price Chart
Executive Summary
The SEC declared CytoDyn's S-3 shelf registration (File No. 333-299150) effective on October 7, 2026. This allows the company to conduct future securities offerings on a delayed or continuous basis, creating potential dilution overhang. The shelf covers up to 794,972,289 shares of common stock, including 410,046,456 shares held by selling stockholders and 384,925,833 shares underlying warrants, with the stock closing at $0.21 per share on September 24, 2026.
Key Facts
- S-3 shelf registration declared effective on October 7, 2026
- Registration covers up to 794,972,289 shares of common stock
- Includes 410,046,456 shares held by selling stockholders and 384,925,833 shares underlying warrants
- Stock closed at $0.21 per share on September 24, 2026
- Company will not receive proceeds from share sales by selling stockholders, but may receive proceeds from warrant exercises
- Prior S-1 filing (April 2026) also went effective, indicating ongoing capital markets activity
Financial Impact
Potential dilution of up to 794,972,289 shares, representing a significant overhang relative to the current share price of $0.21. At that price, the maximum potential offering value is approximately $167 million, though actual sales are at the discretion of selling stockholders.
Risk Factors
- Significant dilution risk from potential share sales by selling stockholders
- Potential downward pressure on stock price due to overhang
- Company may not receive proceeds from share sales, limiting benefit to the company
- Warrant exercise could add further dilution
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| EFFECT Filing (Primary) | 9999999995-26-003176 |
| Document: 9999999995-26-003176-index.html | 9999999995-26-003176 |
| Document: 9999999995-26-003176.txt | 9999999995-26-003176 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 19, 2026 6d ago | DEFA14A | $0.2500 $0.2500 | · 0.00% | ▼ −0.53% | $0.2600 (+4.00%) |
Oct 19, 2026 6d ago | 8-K | $0.2500 $0.2500 | · 0.00% | ▼ −0.53% | $0.2600 (+4.00%) |
Oct 8, 2026 18d ago | EFFECT | $0.2000 $0.2000 | · 0.00% | ▲ +0.60% | $0.2600 (−30.00%) |
Oct 5, 2026 21d ago | EFFECT | $0.2000 $0.2000 | · 0.00% | ▲ +0.55% | $0.2600 (−30.00%) |
Oct 5, 2026 21d ago | EFFECT | $0.2000 $0.2000 | · 0.00% | ▲ +0.55% | $0.2600 (−30.00%) |
Sep 25, 2026 4w ago | S-3 | $0.2200 $0.2000 | ▲ +9.09% | ▲ +8.91% | $0.2600 (−18.18%) |
Mar 5, 2026 33w ago | 8-K | $0.2400 $0.2300 | ▲ +4.17% | ▲ +2.85% | $0.2600 (−8.33%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers